TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cogstate Ltd ( (AU:CGS) ) has shared an announcement.
Cogstate Limited announced a change in the director’s interest, specifically involving Martyn Myer. The notice reveals that 2,500,000 ordinary shares were transferred from Myer and Myer Pty Ltd ATF Whereabouts Superannuation Fund to Trilane Industries Limited, both indirectly associated with Martyn Myer. This change reflects a reallocation of shares within entities linked to the director, potentially impacting the company’s shareholder structure and signaling strategic financial adjustments.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Limited operates in the healthcare industry, specializing in cognitive science and technology. The company provides digital cognitive assessment tools and services, primarily focusing on clinical trials, healthcare, and academic research to measure cognitive function.
Average Trading Volume: 146,364
Technical Sentiment Signal: Buy
Current Market Cap: A$302.7M
Learn more about CGS stock on TipRanks’ Stock Analysis page.